Categories

Above the Fold

Can Apple Teach Silicon Valley to Think Different About Healthcare?

Screen Shot 2016-06-29 at 4.22.24 PMI was thrilled to learn that Stephen Friend, co-founder and CEO of the nonprofit open data platform Sage Bionetworks, has accepted a role at Apple and is stepping away from day-to-day operations at Sage (he will continue to serve as chair of the board).

I’ve known Friend for over decade, starting when I was at Merck (he led cancer research), and continuing through his cofounding of Sage with Eric Schadt (I was at the Boston Consulting Group by then and served as a founding advisor).

(Disclosure/reminder: I am chief medical officer of DNAnexus, a cloud-based health data management platform based in Silicon Valley.)

Under Friend’s leadership, Sage pursued a powerful vision of open science, where data are richly shared and scientists (and citizen-scientists) collaborate to accelerate knowledge turns–a point Josh Sommer (later a Forbes 30 Under 30 awardee) made at the First Sage Commons Congress in 2010, as I described in an early Forbes post, here.

Continue reading…

The Patient and the Snake Oil Salesman

Screen Shot 2016-06-28 at 12.17.51 PM

On June 11, 2016, James Madara, MD., addressed the American Medical Association’s Annual Meeting with some wonderful hyperbole. Dr. Madara is the CEO of the AMA, and he likely felt some pressure to rally the troops (a/k/a physicians) and show that the AMA is advocating for their “side.” And it got attention, with articles trumpeting that Dr. Madara called digital products “modern-day ‘snake oil’.” He indeed did.

We do need to give Dr. Madara a little leeway here.  The role of the AMA is to represent physicians, and he’s the CEO.  That being said, consider for the moment that one of the major points Dr. Madara made was to tout how the AMA’s predecessors over 100 years ago outed snake oil for the fraud it was, thereby protecting the consuming public.  While it was a while ago, the AMA should be rightly proud of that accomplishment.

However, what Dr. Madara did at the June AMA meeting, entertaining as it was, does not deserve equal accolades.

Continue reading…

Medicare’s Long-Term Fiscal Peril Deserves More Attention

Steve FindlayThis year’s release of the annual Medicare Trustee’s report on June 22—261 pages of mind-numbing healthcare and budget minutiae—coincided with the release of the House Republican’s long-awaited alternative to Obamacare.   

Coincided, but not coincidence.  Republicans’ sought to leverage the annual report’s hand-wringing about Medicare’s fiscal unsustainability—to draw attention to their proposals.     

Indeed, the GOP plan garnered the news spotlight.  But it’s the Trustee’s report that deserves closer attention and has more long-term import.   

Continue reading…

Retraction and the Rise of the Truth Jihadis

Screen Shot 2016-06-27 at 9.17.12 AMA petition to the British Medical Journal (BMJ) asking for Makary’s paper on medical errors to be retracted has received over 100 signatures. I, amongst others, criticized Makary’s analysis. But I shall not be signing the petition.

I applaud the editor of the BMJ, and the section editor, for publishing Makary’s analysis. The analysis was in the right journal in the right section. To be clear, I believe the editors did nothing wrong publishing the paper. The role of medical journals is not to tell us how to think, but what to think about, which the BMJ achieved.

Makary’s analysis was provocative. I almost developed laryngeal edema reading it. The analysis advanced the discourse about medical errors. The analysis made doctors think, think beyond dull platitudes. The analysis broke the taboo of questioning the number of deaths from medical errors. Whether or not this was the intention of the authors is immaterial. The BMJ achieved a vigorous debate about medical errors. Not since the NEJM series on physician relationship with industry has any publication led to such intense discourse.

Some say that the paper should be retracted because it was a scientific paper, not an opinion, and as science it is even more dubious. This is not true. The paper was an “analysis.” Look up the definition of “analysis.” But were it research, so what? Methodology for this this type of research is flawed. If all research with fallible methods are retracted, that’ll end medical research.

Some say that the paper should be retracted because the media runs with the story amplifying the error. The media is fickle. The media runs like decerebrate pigeons every time a nutritional study is published. The media doesn’t know its posterior from elbow and I, for one, find this state of affairs comical. I find it hilarious when someone, who follows nutritional advice as punctiliously as a celibate nun listens to her pastor, is later told that it is all rubbish. Nothing gives me more pleasure than seeing mirthless optimizers taken down the garden path.

It is true that the media will be quoting “medical errors are the third leading cause of death” for years. However, the root cause of this chicanery is not Makary’s analysis but the Institute of Medicine (IOM) report: To Err is Human, which stated that jumbo jets of hapless patients were crashing daily. The report created a new science and a professional empire. Should the IOM retract that report?

Continue reading…

Just-in-Time Healthcare Information

flying cadeuciiOne of the things that can cause physician burnout is the arcane way information flows in medical offices. In essence, due to EMRs we are the recipients of increasing amounts of unfiltered data without context.

Pre-EMR, team members sorted incoming data, which allowed us to deal with it more efficiently. We would have piles of things that needed a signature just as a formality, other piles for normal reports, smaller piles for abnormal reports, or whatever system worked best for us and our practices.

Because EMRs were created by people who never imagined that doctors themselves knew anything about how to maximize their own efficiency, results and reports now fill our inboxes in random order and demand our attention and our electronic signatures more or less immediately.

There is a better way. It is standard practice in manufacturing. They call it “Just in Time”.

Continue reading…

The Orlando Shootings and Homophobia in Healthcare

Screen Shot 2016-06-25 at 5.01.26 PM
After the horrific shooting in in Orlando, the conversation has turned to homophobia—specifically, the homophobia of a man who sees two men kissing, buys an AR-15, goes to a gay nightclub, and killed 49 individuals.  But homophobia does not always come with a high capacity rifle—sometimes it comes with lab coats and syringes.  As the 53 individuals who were critically injured in the shooting receive medical care, we must come to terms with the anti-gay discrimination that pervades our medical system.

Continue reading…

Time to Brexit the Health Care System?

Screen Shot 2016-06-24 at 10.52.58 AM

Can’t. Won’t work. We’re stuck with this. We have to fix it.

But “Brexit” was a great logo/hashtag/campaign meme, with echoes of “Britain, break it, exit” all in one. Falls right off the tongue, it does. And it described fairly exactly the mood behind it, one of breaking, getting out.

So in healthcare? Time to FFSexit — exit the fee for service business model. Nah, doesn’t trip off the tongue. And it has echoes of “sex” and even “sexist.” Next!

Time to ITexit — exit the non-interoprative, non-communicative garbled EHRs and other information systems we have ended up with. Nope, nope. Sounds too much like inviting Texas to re-think this whole annexation thing.

Time to Vexit — exit the volume-based business model. Hmmm, no. Sounds vexatious, vexed.

Time to exit the fragmented, opaque, partial, byzantine, and outright cruel healthcare financing system we have now —FragOpParByzOutCrexit! Sigh.

Wait. Wait. Here’s the core problem of this meme-pondering: We don’t want to “exit” healthcare in any way.

Continue reading…

The Great Insurer Fee Disconnect

A message to health insurance CEOs, COOs, and CFOs.  I believe there to be a fundamental disconnect between typical health insurer provider reimbursement strategies and the long term good of our healthcare delivery system and its financing.

Let me give you some examples which I know, as a former health insurer COO and CEO, to be true.

  • Insurers still pay primary care physicians far less than most specialists.  That perhaps was a function of the RBRVS system adopted by Medicare to “measure” the demands of specific physician activities and pay accordingly.  Specialist activities were rated higher than primary care activities.  They were deemed more complex, often involving surgery and fancy equipment with more training needed, etc.  The gap between primary care and specialist reimbursement grew and grew.  And what happened?  Predictably, the best and brightest are avoiding low paying primary care.  Consequences?
  • Shortage and aging of primary care physicians who are needed to keep us from requiring the much more expensive specialist and hospital care
  • Oversupply of specialists resulting in overuse, because if you build it they will come
  • Keeping the focus on sick care, which is what most specialists specialize in, rather than well care
  • Devaluing E&M (evaluative and maintenance) activity, which is the heart and soul of the practice of medicine, requiring observation, patient knowledge, and perception

Continue reading…

Where’s the Value in MACRA?

flying cadeuciiThe intent of Title I of the 2015 Medicare Access and CHIP Reauthorization Act (MACRA) is to improve care quality and reward value. 1  Tying an increasing percent of Medicare fee for service payments to quality or value through alternative payment models such as Accountable Care Organizations (ACOs) is also Department of Health and Human Services Secretary Sylvia Burwell’s goal. 2  However, in the proposed MACRA rule published in May, CMS will measure and score quality and resource use or spending independently. 3  CMS will not measure outcomes in relation to spending.  CMS will not measure for value.  If value is left unaddressed in the final rule the agency can neither meet MACRA’s goals nor Secretary Burwell’s.  CMS cannot also reasonably expect providers to continue to enter into, and succeed under, risk based contacts if they do not know if they are incrementally improving quality or outcomes relative to spending. Continue reading…

The Mischief and the Good In Precision Medicine

Screen Shot 2016-06-22 at 9.03.35 AM

When The White House announced their Precision Medicine Initiative last year, they referred to precision medicine as “a new era of medicine,” signaling a shift in focus from a “one-size-fits-all-approach” to individualized care based on the specific characteristics that distinguish one patient from another. While there continues to be immense excitement about its game-changing impact in terms of early diagnoses and targeting specific treatment options, the advancements in technology, which underlie this approach, may not always yield the best medical results. In some cases, low cost approaches, based on sound clinical judgment, are still the better option.

For example, tuberculosis (TB) is an infectious disease that continues to pose global burden with 9.6 million new cases and 1.5 million deaths reported in 2014 alone. The large toll is partly due to lack of effective treatments (particularly for drug-resistant cases) but also due to delays in diagnosis. One might think that precision medicine technology leading to improved diagnosis would be effective at minimizing the related death toll but we shouldn’t automatically assume that. It turns out that sometimes the latest technological advancements can be so sensitive that we detect organisms that are not causing disease.

Continue reading…

assetto corsa mods